James Hassard Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

ARWR Quotes by TradingView

James Hassard is Chief Commercial Officer of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 105,750 shares of ARWR, which is worth approximately $2.06 Million. The most recent transaction as insider was on Jun 22, 2021, when has been sold 3,625 shares (Common Stock) at a price of $89.22 per share, resulting in proceeds of $323,423. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 106K
0% 3M change
0% 12M change
Total Value Held $2.06 Million

James Hassard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 22 2021
SELL
Open market or private sale
$323,423 $89.22 p/Share
3,625 Reduced 3.31%
105,750 Common Stock
Jan 07 2021
SELL
Open market or private sale
$1,171,875 $75.0 p/Share
15,625 Reduced 12.5%
109,375 Common Stock

Also insider at

CRNX
Crinetics Pharmaceuticals, Inc. Healthcare
Chief Commercial Officer
JH

James Hassard

Chief Commercial Officer
San Diego, CA

Track Institutional and Insider Activities on ARWR

Follow ARROWHEAD PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARWR shares.

Notify only if

Insider Trading

Get notified when an Arrowhead Pharmaceuticals, Inc. insider buys or sells ARWR shares.

Notify only if

News

Receive news related to ARROWHEAD PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARWR